HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients

Hum Immunol. 2001 Feb;62(2):180-5. doi: 10.1016/s0198-8859(00)00249-4.

Abstract

HLA class I polymorphism in Moroccan patients with Behçet's disease has not been investigated so far. In this study, HLA-B* phenotype frequencies were analyzed in 86 unrelated Moroccan patients (45 males, 41 females) and 111 ethnically matched healthy controls. The predisposing effect of the B*51 was confirmed (30.2% in patients and 15.3% in controls, OR = 2.39, 95% CI [1.2-4.8], p = 0.015). It was mostly observed in males with young age at disease onset (OR= 5.5 [1.9-15.9], p = 0.002 compared to controls). The Moroccan BD group also presented a previously unknown association with HLA-B*15 (25.6% of patients versus 11.7% of controls, OR = 2.59 [1.2-5.5], p = 0.014), both in females and in males with late-onset of the disease. Altogether, the B*15 and/or B*51 alleles were expressed in 55.8% of patients compared to 27% of controls (OR = 3.4 [1.9-6.2], p < 10-4, Pc = 0.003). Our data indicate HLA-B effects on BD pathogenesis should be considered separately for men and women.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alleles*
  • Behcet Syndrome / epidemiology
  • Behcet Syndrome / genetics*
  • Behcet Syndrome / immunology*
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease / epidemiology
  • Genetic Predisposition to Disease / genetics*
  • HLA-B Antigens / genetics*
  • HLA-B15 Antigen
  • HLA-B51 Antigen
  • Humans
  • Male
  • Middle Aged
  • Morocco / epidemiology
  • Phenotype
  • Prevalence
  • Sex Factors

Substances

  • HLA-B Antigens
  • HLA-B15 Antigen
  • HLA-B51 Antigen